Page last updated: 2024-11-08

epiafzelechin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

epiafzelechin: antioxidant; 3'-deoxy form of epicatechin; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(-)-epiafzelechin : A catechin derivative having (2R,3R)-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID443639
CHEMBL ID159303
CHEBI ID31028
SCHEMBL ID557061
MeSH IDM0331821

Synonyms (41)

Synonym
(2r,3r)-epiafzelechin
24808-04-6
BRD-K90607708-001-02-9
BSPBIO_003210
SDCCGMLS-0066933.P001
NCGC00178206-01
(-)-epiafzelechin
epi-afzelechin
(2r,3r)-2-(4-hydroxyphenyl)chromane-3,5,7-triol
2-(4-hydroxyphenyl)chromane-3,5,7-triol
KBIO3_002430
SPECTRUM3_001685
SPECTRUM2_001755
SPBIO_001890
SPECTRUM202178
2,3-cis-epiafzelechin
(2r,3r)-2-(4-hydroxy-phenyl)-chroman-3,5,7-triol
bdbm50240892
(2r,3r)-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromene-3,5,7-triol
CHEMBL159303 ,
chebi:31028 ,
LMPK12020036
epiafzelechin
CCG-38806
SCHEMBL557061
epiafzelechin (2r,3r)(-)
SR-05000002523-1
sr-05000002523
AKOS032948425
Q4690888
BRD-K90607708-001-03-7
CS-0016076
2h-1-benzopyran-3,5,7-triol, 3,4-dihydro-2-(4-hydroxyphenyl)-, (2r,3r)-
AS-79066
HY-N0943
A930314
(2r,3r)-2-(4-hydroxyphenyl)-3,5,7-chromantriol
(2r,3r)-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
DTXSID201316359
E80545
GLXC-17278

Research Excerpts

Overview

Epiafzelechin is a flavan-3-ol commonly found in plant source.

ExcerptReferenceRelevance
"(-)-Epiafzelechin is a flavan-3-ol commonly found in plant source. "( Development of a UPLC-MS/MS bioanalytical method for the pharmacokinetic study of (-)-epiafzelechin, a flavan-3-ol with osteoprotective activity, in C57BL/6J mice.
Chan, TH; Law, MC; Wong, KC; Wong, MS, 2014
)
1.18
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
catechinMembers of the class of hydroxyflavan that have a flavan-3-ol skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Flavonoid Biosynthesis1150
2,3-cis-flavanols biosynthesis19
2,3-cis-flavanols biosynthesis09

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Synaptojanin-2Homo sapiens (human)IC50 (µMol)15.90000.87404.137310.0000AID1620742; AID1621365; AID1634424
Synaptojanin-1Homo sapiens (human)IC50 (µMol)15.90001.00001.00001.0000AID1620743; AID1621366
Prostaglandin G/H synthase 1Homo sapiens (human)IC50 (µMol)10.70000.00021.557410.0000AID332217; AID403341
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)69.70000.00010.995010.0000AID332218
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (72)

Processvia Protein(s)Taxonomy
phosphatidylinositol biosynthetic processSynaptojanin-2Homo sapiens (human)
phosphatidylinositol-3-phosphate biosynthetic processSynaptojanin-2Homo sapiens (human)
synaptic vesicle endocytosisSynaptojanin-2Homo sapiens (human)
membrane organizationSynaptojanin-2Homo sapiens (human)
phosphatidylinositol dephosphorylationSynaptojanin-2Homo sapiens (human)
phosphatidylinositol biosynthetic processSynaptojanin-1Homo sapiens (human)
neurotransmitter transportSynaptojanin-1Homo sapiens (human)
learningSynaptojanin-1Homo sapiens (human)
synaptic vesicle primingSynaptojanin-1Homo sapiens (human)
synaptic vesicle uncoatingSynaptojanin-1Homo sapiens (human)
phosphatidylinositol-3-phosphate biosynthetic processSynaptojanin-1Homo sapiens (human)
inositol phosphate metabolic processSynaptojanin-1Homo sapiens (human)
phosphatidylinositol metabolic processSynaptojanin-1Homo sapiens (human)
phosphatidylinositol dephosphorylationSynaptojanin-1Homo sapiens (human)
synaptic vesicle endocytosisSynaptojanin-1Homo sapiens (human)
synaptic vesicle transportSynaptojanin-1Homo sapiens (human)
membrane organizationSynaptojanin-1Homo sapiens (human)
positive regulation of endosome organizationSynaptojanin-1Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 1Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 1Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 1Homo sapiens (human)
regulation of cell population proliferationProstaglandin G/H synthase 1Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (19)

Processvia Protein(s)Taxonomy
RNA bindingSynaptojanin-2Homo sapiens (human)
phosphatidylinositol-3-phosphate phosphatase activitySynaptojanin-2Homo sapiens (human)
phosphatidylinositol-4,5-bisphosphate 5-phosphatase activitySynaptojanin-2Homo sapiens (human)
protein bindingSynaptojanin-2Homo sapiens (human)
phosphatidylinositol phosphate 4-phosphatase activitySynaptojanin-2Homo sapiens (human)
phosphatidylinositol-3,5-bisphosphate 5-phosphatase activitySynaptojanin-2Homo sapiens (human)
phosphatidylinositol-3,5-bisphosphate 3-phosphatase activitySynaptojanin-2Homo sapiens (human)
SH3 domain bindingSynaptojanin-2Homo sapiens (human)
PDZ domain bindingSynaptojanin-2Homo sapiens (human)
RNA bindingSynaptojanin-1Homo sapiens (human)
phosphatidylinositol-3-phosphate phosphatase activitySynaptojanin-1Homo sapiens (human)
phosphatidylinositol-4,5-bisphosphate 5-phosphatase activitySynaptojanin-1Homo sapiens (human)
protein bindingSynaptojanin-1Homo sapiens (human)
phosphatidylinositol phosphate 5-phosphatase activitySynaptojanin-1Homo sapiens (human)
phosphatidylinositol phosphate 4-phosphatase activitySynaptojanin-1Homo sapiens (human)
phosphatidylinositol-4-phosphate phosphatase activitySynaptojanin-1Homo sapiens (human)
phosphatidylinositol-3,5-bisphosphate 5-phosphatase activitySynaptojanin-1Homo sapiens (human)
phosphatidylinositol-3,5-bisphosphate 3-phosphatase activitySynaptojanin-1Homo sapiens (human)
inositol-1,4,5-trisphosphate 5-phosphatase activitySynaptojanin-1Homo sapiens (human)
SH3 domain bindingSynaptojanin-1Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 1Homo sapiens (human)
protein bindingProstaglandin G/H synthase 1Homo sapiens (human)
heme bindingProstaglandin G/H synthase 1Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 1Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 1Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (26)

Processvia Protein(s)Taxonomy
cytosolSynaptojanin-2Homo sapiens (human)
cytoskeletonSynaptojanin-2Homo sapiens (human)
plasma membraneSynaptojanin-2Homo sapiens (human)
cell projectionSynaptojanin-2Homo sapiens (human)
membrane raftSynaptojanin-2Homo sapiens (human)
perinuclear region of cytoplasmSynaptojanin-2Homo sapiens (human)
presynapseSynaptojanin-2Homo sapiens (human)
microtubuleSynaptojanin-1Homo sapiens (human)
cytosolSynaptojanin-1Homo sapiens (human)
vesicle membraneSynaptojanin-1Homo sapiens (human)
terminal boutonSynaptojanin-1Homo sapiens (human)
perinuclear region of cytoplasmSynaptojanin-1Homo sapiens (human)
synaptic membraneSynaptojanin-1Homo sapiens (human)
presynapseSynaptojanin-1Homo sapiens (human)
membrane coatSynaptojanin-1Homo sapiens (human)
clathrin coat of coated pitSynaptojanin-1Homo sapiens (human)
perinuclear region of cytoplasmSynaptojanin-1Homo sapiens (human)
presynapseSynaptojanin-1Homo sapiens (human)
photoreceptor outer segmentProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1Homo sapiens (human)
Golgi apparatusProstaglandin G/H synthase 1Homo sapiens (human)
intracellular membrane-bounded organelleProstaglandin G/H synthase 1Homo sapiens (human)
extracellular exosomeProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 1Homo sapiens (human)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID592417Inhibition of H2O2-induced lipid peroxidation in rat liver homogenates assessed as malondialdehyde level after 4 hrs2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Epiafzelechin from the root bark of Cassia sieberiana: detection by DART mass spectrometry, spectroscopic characterization, and antioxidant properties.
AID403341Inhibition of COX12005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID332218Inhibition of COX22002Journal of natural products, Feb, Volume: 65, Issue:2
Constituents of the bark and twigs of Artocarpus dadah with cyclooxygenase inhibitory activity.
AID332219Inhibition of DMBA-induced preneoplastic lesions in mouse mammary gland organ culture at 10 ug/mL2002Journal of natural products, Feb, Volume: 65, Issue:2
Constituents of the bark and twigs of Artocarpus dadah with cyclooxygenase inhibitory activity.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID592415Antioxidant activity assessed as ferric ion reducing activity using fe3+-TPTZ at 40 ug/ml by FRAP assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Epiafzelechin from the root bark of Cassia sieberiana: detection by DART mass spectrometry, spectroscopic characterization, and antioxidant properties.
AID358554Antioxidant activity assessed as DPPH radical scavenging activity2001Journal of natural products, Jan, Volume: 64, Issue:1
Antioxidant benzoylated flavan-3-ol glycoside from Celastrus orbiculatus.
AID647813Antifilarial activity against microfilariae Brugia malayi assessed as inhibition of motility at 31.25 ug/ml incubated for 48 hrs followed by washout measured after 1 hr in the absence of drug by microscopic analysis2012European journal of medicinal chemistry, Apr, Volume: 50Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi.
AID592416Antioxidant activity assessed as ferric ion reducing activity using fe3+-TPTZ at 80 ug/ml by FRAP assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Epiafzelechin from the root bark of Cassia sieberiana: detection by DART mass spectrometry, spectroscopic characterization, and antioxidant properties.
AID647808Antifilarial activity against adult Brugia malayi assessed as inhibition of motility at 31.25 ug/ml incubated for 48 hrs followed by washout measured after 1 hr in the absence of drug by microscopic analysis2012European journal of medicinal chemistry, Apr, Volume: 50Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi.
AID592418Inhibition of H2O2-induced lipid peroxidation in rat liver homogenates assessed as malondialdehyde level at 80 ug/ml after 4 hrs2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Epiafzelechin from the root bark of Cassia sieberiana: detection by DART mass spectrometry, spectroscopic characterization, and antioxidant properties.
AID456182Inhibition of reduced carboxymethylated kappa-casein fibril formation at 100 ug/mL measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID332217Inhibition of COX12002Journal of natural products, Feb, Volume: 65, Issue:2
Constituents of the bark and twigs of Artocarpus dadah with cyclooxygenase inhibitory activity.
AID592413Antioxidant activity assessed as DPPH radical scavenging activity2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Epiafzelechin from the root bark of Cassia sieberiana: detection by DART mass spectrometry, spectroscopic characterization, and antioxidant properties.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID592414Antioxidant activity assessed as ferric ion reducing activity using fe3+-TPTZ at 20 ug/ml by FRAP assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Epiafzelechin from the root bark of Cassia sieberiana: detection by DART mass spectrometry, spectroscopic characterization, and antioxidant properties.
AID647818Antifilarial activity against adult Brugia malayi at 31.25 ug/ml by MTT assay relative to control2012European journal of medicinal chemistry, Apr, Volume: 50Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.35)18.2507
2000's4 (17.39)29.6817
2010's15 (65.22)24.3611
2020's3 (13.04)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.46 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.31 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]